Efficacy of artequick® versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 39, Issue 1, 2008, Pages 1-8

  Tangpukdee, Noppadon ^a   Krudsood, Srivicha ^a   Thanachartwet, Vipa ^a   Pengruksa, Chaweewan ^a   Phophak, Nanthaporn ^a   Kano, Shigeyuki ^b   Li, Guoqiao ^c   Brittenham, Gary M ^d   Looareesuwan, Sornchai ^a   Wilairatana, Polrat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^d Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; MEFLOQUINE; PIPERAQUINE; PRIMAQUINE; QUINOLINE DERIVATIVE;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; MIDDLE AGED; PARASITOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THAILAND; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; PRIMAQUINE; PROSPECTIVE STUDIES; QUINOLINES; THAILAND; TREATMENT OUTCOME;

EID: 39649095189     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ashley EA, White NJ. Artemisinin-based combinations. Curr Opin Infect Dis 2005; 18: 531-6.
2. Breman JG, Alilio MS, Mills A. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg 2004; 71: 1-15.
3. Davis TM, Hung TY, Sim IK, Karunajeewa HA, Ilett KF. Piperaquine: a resurgent antimalarial drug. Drugs 2005; 65: 75-87.
4. Denis MB, Davis TM, Hewitt S, et al. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin Infect Dis 2002; 35: 1469-76.
5. Hien TT, Dolecek C, Mai PP. Dihydroartemisininpiperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomized clinical trial. Lancet 2004; 363: 18-22.
6. Kumar N, Zheng H. Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol Res 1990; 76: 214-8.
7. Looareesuwan S, Wilairatana P, Vanijanonta S, Pitisuttithum P, Ratanapong Y, Andrial M. Monotherapy with artesunate for uncomplicated falciparum malaria: a comparison of 5-day and 7-day regimens. Acta Trop 1997; 67: 197-205.
8. Nosten F, Luxemburger C, ter Kuile FO, et al. Treatment of multidrug-resistant P. falciparum malaria with 3-day artesunate- mefloquine combination. J Infect Dis 1994; 170: 917-27.
9. Ratcliff A, Siswantoro H, Kenangalem E, et al. Two fixed dose artemisinin combinations for drug resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomized comparison. Lancet 2007; 369: 757-65.
10. Silachamroon U, Krudsood S, Thanachartwet W, et al. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health 2005; 36: 591-6.
11. Smithuis F, Kyaw MK, Phe O, et al. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomized comparison. Lancet 2006; 367: 2075-85.
12. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434: 214-7.
13. Stepniewska K, White NJ. Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria. Malaria J 2006; 5: 127.
14. Tarning J, Lindegardh N, Annerberg A, et al. Pitfalls in estimating piperaquine elimination. Antimicrob Agents Chemother 2005; 49: 5127-8.
15. Tropical Medicine Institute. Documentation of Artequick® for new drug registration. Guangzhou, China: Guangzhou University of Traditional Chinese Medicine, 2004.
16. Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A, Wongsrichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health 2006; 11: 211-9.
17. World Health Organization. Antimalarial drug combination therapy: report of a WHO technical consultation. 2001. [Cited 2005 Dec 7]. Available from: URL: http://ww.whoglibdoc.who.int/hq/2001/WHO_CDS_RBM_2001.35pdf
18. World Health Organization. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: WHO, 2003a.
19. World Health Organization. Toxicity grading scale for determining the severity of adverse events. 2003b. [Cited 2006 Mar 14]. Available from: URL: http://www.icsssc.orq/documents/20final.pdf
20. st ed. Geneva: WHO, 2006.
21. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94 (suppl 1): 1-90.